Stock Price
345.10
Daily Change
-4.90 -1.40%
Monthly
6.97%
Yearly
-61.09%
Q3 Forecast
344.93

Novo Nordisk reported 12.85B in Cost of Sales for its fiscal quarter ending in June of 2025.




Cost Of Sales Change Date
Bausch Health Companies USD 764M 63M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Merck USD 2.82B 53M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Novo Nordisk 12.85B 44M Jun/2025
Novo Nordisk DKK 12.89B 1.58B Mar/2025
Pacira USD 55.19M 20.88M Jun/2025
Sanofi EUR 2.99B 103M Jun/2025
Supernus Pharmaceuticals USD 37.65M 21.88M Jun/2025